Adropin a candidate diagnostic biomarker for cardiovascular disease in patients with chronic kidney disease
Background: Chronic kidney disease (CKD) is a chief worldwide health concern that has a substantial financial impact on health systems, high rates of mortality and morbidity as well as cardiovascular disease (CVD) is a major cause of mortality in this population. Adropin is a unique hormone encoded...
Saved in:
| Main Authors: | Maha Abd El Moneem Elfedawy, Samia Abd El Sadek Elsebai, Hend Mohamed Tawfik, Eman Refaat Youness, Moushira Zaki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Journal of Genetic Engineering and Biotechnology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1687157X24001410 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases
by: Junmin Wang, et al.
Published: (2025-01-01) -
Adropin exerts neuroprotection in an experimental rat model of Parkinson’s disease
by: Ayse Ozkan, et al.
Published: (2025-06-01) -
Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
by: I-Wen Chen, et al.
Published: (2025-02-01) -
The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors
by: Samaa Salah Abd-El-Fatah, et al.
Published: (2024-12-01) -
Adropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse
by: Shweta Maurya, et al.
Published: (2025-03-01)